BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35611989)

  • 1. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma.
    Chen PT; Hsieh CC; Chen MF
    Mol Carcinog; 2022 Aug; 61(8):787-796. PubMed ID: 35611989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling.
    Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF
    Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of interleukin-6 in the radiation response of liver tumors.
    Chen MF; Hsieh CC; Chen WC; Lai CH
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e621-30. PubMed ID: 22975618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma.
    Chen MF; Chen PT; Hsieh CC; Wang CC
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 1α,25-Dihydroxyvitamin D3 on the Radiation Response in Prostate Cancer: Association With IL-6 Signaling.
    Wu CT; Huang YC; Chen WC; Chen MF
    Front Oncol; 2021; 11():619365. PubMed ID: 34109109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1, 25(OH)₂D₃ inhibits hepatocellular carcinoma development through reducing secretion of inflammatory cytokines from immunocytes.
    Guo J; Ma Z; Ma Q; Wu Z; Fan P; Zhou X; Chen L; Zhou S; Goltzman D; Miao D; Wu E
    Curr Med Chem; 2013; 20(33):4131-41. PubMed ID: 23992309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment.
    Zhang J; Zhang Q; Lou Y; Fu Q; Chen Q; Wei T; Yang J; Tang J; Wang J; Chen Y; Zhang X; Zhang J; Bai X; Liang T
    Hepatology; 2018 May; 67(5):1872-1889. PubMed ID: 29171040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 10. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
    Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
    Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
    Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of IL-6 in the radiation response of prostate cancer.
    Wu CT; Chen MF; Chen WC; Hsieh CC
    Radiat Oncol; 2013 Jun; 8():159. PubMed ID: 23806095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
    Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
    Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
    Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
    J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/β-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma.
    Huang Y; Sheng H; Xiao Y; Hu W; Zhang Z; Chen Y; Zhu Z; Wu D; Cao C; Sun J
    Radiother Oncol; 2021 Sep; 162():34-44. PubMed ID: 34214613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Potential of (-)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge
    Choi C; Cho Y; Son A; Shin SW; Lee YJ; Park HC
    Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 33003597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
    Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
    Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
    Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
    Gu FM; Li QL; Gao Q; Jiang JH; Zhu K; Huang XY; Pan JF; Yan J; Hu JH; Wang Z; Dai Z; Fan J; Zhou J
    Mol Cancer; 2011 Dec; 10():150. PubMed ID: 22171994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.